SARS-CoV-2 Nucleoprotein CTD Domain

REQUEST MORE INFO
Catalogue No: abx163975
Price: US$304.50
(Size: 50 µg)

Click on the image to see the image legend

Available Options

* Size:


Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleoprotein CTD Domain is a recombinant protein expressed in E. coli.

The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.

Target Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleoprotein CTD Domain
Origin Virus
Expression Recombinant
Tested Applications ELISA, WB, SDS-PAGE
Host E. coli
Recommended dilutions Optimal dilutions/concentrations should be determined by the end user.
Conjugation Unconjugated
Form Liquid
Purity > 95% (SDS-PAGE)
Purification 0.2 µm filtered.
Storage Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
NCBI Accession QHD43423.2
Tag N-terminal 6 His tag
Buffer PBS, 2 M Urea, pH 7.4.
Endotoxin Level < 0.1 ng/µg (1 IEU/µg) as determined by LAL test.
Availability Shipped within 7-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Nucleoprotein CTD Domain


Write a review

Tags:
(Click to show)